Back

Infection and Immunity nieuws

Infection and Immunity nieuws

Jun 20: IgA antibody therapy may be a viable alternative therapy in high-risk neuroblastoma

PhD research by Marjolein Stip has shown that IgA-based antibody therapy may be a viable alternative for IgG anti-GD2 antibody therapy in the treatment of high-risk neuroblastoma. In vitro studies suggest that IgA-based therapy (in contrast to IgG-based antibodies) is not associated with neuropathic pain while maintaining clinical efficacy.

Read more


Jun 7: A critical appraisal of clinical decision support systems for immune diseases

This PhD thesis by Marianne Messelink (UMC Utrecht) describes the development, validation and evaluation of clinical decision support systems for rheumatoid arthritis and primary antibody deficiency. Such systems have the potential to advance diagnoses and optimize treatments. However, there are also challenges and pitfalls in their development and implementation. Ultimately, the focus should not be on the predictive value, but on the real benefit to the patient and healthcare system.

Read more


Jun 6: Lymphocyte dynamics in a more natural mouse model

Lymphocyte dynamics research by Elena de Dios Panal (UMC Utrecht) shows that animal models provided valuable information that could hardly or not at all be obtained from humans. However, the discrepancies between human and murine immune dynamics found in parts of this thesis highlight some fundamental differences between murine and human immune cell maintenance. While animal models still hold potential, their critical discussion remains crucial.

Read more


Patricia Bruijning-Verhagen appointed professor of vaccination and infection control epidemiology

Portrait picture of Patricia Bruijning, professor of vaccination and infection control epidemiology

Utrecht University and UMC Utrecht have announced the appointment of Patricia Bruijning-Verhagen as professor of vaccination and infection control epidemiology, effective June 1, 2024. This position will enable Patricia to continue her work in designing and evaluating optimal infection prevention policies through vaccination and other innovative strategies. Her appointment comes at a crucial time, as the world faces the dual challenge of emerging infectious diseases and an expanding portfolio of vaccines.

Read more


June 3: Life span of lymphocytes further unraveled

In her PhD thesis, Carina Bruckmaier (UMC Utrecht) explored lymphocyte dynamics in various tissue sites in homeostasis and during imbalanced states. In particular, her research on the life span of some of the lymphocyte subcategories revealed some interesting new insights.

Read more


May 29: Unveiling the mysteries of smell: research on COVID-19-related smell loss

During the COVID-19 pandemic – especially during the first wave of infections- a large number of people infected with the SARS-CoV-2 virus reported a sudden loss of smell. Dutch investigators quickly set up a series of studies on diagnosis, pathophysiology, epidemiology, clinical course and treatment of COVID-19-induced loss of smell. The PhD thesis by Emma Schepens (UMC Utrecht) provides some interesting and valuable insights on this unexpected clinical finding.

Read more


May 27: New research provides further evidence that pediatric uveitis is a systemic immune disease

Pediatric uveitis might be a manifestation of a disease that affects not only the eye but also the systemic immune system and microcirculation. Therefore, it is important to adopt a multidisciplinary approach in the management of pediatric uveitis patients to provide the best possible care. These were the main takeaways from the PhD research by Carlyn Kouwenberg from UMC Utrecht.

Read more


Alternatives to antibiotics: Adapting phages to overcome bacterial defense barriers

3D rendering of bacteriophage

Collaborating researchers from University Medical Center Utrecht and Delft University of Technology have received funding from the Dutch Research Council (NWO) to develop more broadly acting bacteriophages. With help of such adapted phages, the researchers want to overcome bacterial defense barriers, which are important mechanisms in the bacterial resistance against bacteriophages.

Read more


Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Read more


Apr 23: Existing drugs now available in study for patients with rare immune diseases

Hand of a man with rheumatoid arthritis

This DRIMID study will investigate the efficacy and safety of the drug filgotinib (approved for treatment of rheumatoid arthritis and ulcerative colitis) in three rare immune diseases (Behçet's disease, idiopathic inflammatory myositis, IgG4-related disease)

Read more


Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not